-
Mashup Score: 0Collection Details : Oncology Times - 2 hour(s) ago
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Collection Details : Oncology Times - 1 day(s) ago
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
Women in their 40s and older should get a mammogram every other year, according to official new guidelines from the U.S. Preventive Services Task Force.
Source: www.nbcnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4
Overall, GHS and quality of life were maintained for both treatment groups, with prespecified PRO variables favouring trastuzumab deruxtecan over treatment of physician’s choice, suggesting that despite a longer treatment duration, there was no detrimental impact on patient health-related quality of life with trastuzumab deruxtecan. When considered with efficacy and safety data from DESTINY-Breast02, these results support the overall benefit of trastuzumab deruxtecan for patients with HER2-positive unresectable or metastatic breast cancer previously treated with trastuzumab emtansine.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion - 2 day(s) ago
MIF secreted by breast cancer stem cells induces metabolic reprogramming in bulk tumor cells and engenders an immunosuppressive microenvironment, identifying MIF targeting as a strategy to improve immunotherapy efficacy in breast cancer.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Commentary on: Yao MM, Vy VPT, Chen TH, Hsu HH, Hsu GC, Lee CS, Lin LJ, Chia SL, Wu CC, Chan WP, Yen AM. Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004-2020. BMC Med. 2023 Dec 15;21(1):497. doi: 10.1186/s12916-023-03217-7. ### Implications for practice and research Breast cancer continues to be a major public health concern, affecting millions of women globally each year.1 An early diagnosis using mammography is crucial for a successful treatment and better quality of life.2 Many women still do not receive regular mammography screening due to factors such as lack of awareness or limited access.3 Yao et al evaluated the impact of Taiwan’s Breast Cancer Screening …
Source: ebn.bmj.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 4Collection Details : Oncology Times - 5 day(s) ago
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 82ICR researcher wins prestigious clinical science award - 6 day(s) ago
Dr Stephen-John Sammut, a Clinician Scientist at The Institute of Cancer Research, London, and Honorary Consultant in Medical Oncology at The Royal Marsden NHS Foundation Trust, has been awarded the Graham Bull Prize by the Royal College of Physicians for his work in personalised breast cancer medicine.
Source: www.icr.ac.ukCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
71K likes, 1,388 comments – leannehainsby on April 21, 2024: “So proud of us. Today, we completed the 2024 London Marathon 🎉🙌🏻 What’s even more amazing than that is that we have (currently…”.
Source: www.instagram.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Collection Details : Oncology Times - 7 day(s) ago
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
New research suggests that being overweight or obese can reduce the benefit of extending adjuvant #breastcancer hormone therapy in women younger than 60 years. Listen to Senna W.M. Lammers, MD, discuss the research: https://t.co/NFIiUzGmXs https://t.co/MvI4XsOaf1